ASML's Order Book Is Full Through 2028 — So Why Are Big Money Managers So Split?

ASML's capacity is booked through 2028, yet institutional investors diverge sharply on valuation as High-NA demand lags and geopolitical risks loom.

The Dutch lithography giant finds itself in an unusual position: its factories are effectively sold out for the next two and a half years, yet the investor base circling the stock cannot agree on what it is worth.

ASML has confirmed that production capacity for its EUV and immersion systems is practically fully booked through the end of 2028, and has pledged to expand capacity for 2027 by roughly 30 percent. That demand visibility would normally settle any valuation debate. It hasn't. Regulatory filings for the second quarter reveal a striking divergence among institutional shareholders, with some of the world's largest asset managers moving in opposite directions at the same time.

Dan Loeb's Third Point added 150 percent to its position, lifting its stake from 12,000 to 30,000 shares. Caitong International Asset Management went further still, expanding its holding by a remarkable 611.1 percent. Mitsubishi UFJ, Greenwoods Asset Management of Hong Kong, BlackRock, T. Rowe Price and Fisher Asset Management — already a heavyweight with over 4.4 million shares — all bought more. Fisher added another 3 percent.

The sellers tell a different story. Deutsche Bank cut its ASML position by 44 percent during the quarter, Deepwater Asset Management slashed its stake by 72.3 percent, and Coatue Management trimmed 41 percent. The churn suggests that after a ferocious twelve-month rally, the debate over ASML's valuation has become genuinely contentious — even as the company's operational outlook has rarely looked firmer.

The High-NA Paradox: A Technological Monopoly Customers Won't Rush to Buy

The tension at the shareholder level mirrors a deeper strategic puzzle inside ASML's product line. The company's High-NA EUV systems represent a genuine technological monopoly — the most expensive and complex lithography machines ever built, priced between $350 million and $410 million apiece. But the customers who would buy them are in no hurry.

Intel has become the first chipmaker to deploy High-NA in high-volume manufacturing, using the systems for selected layers of its "Panther Lake" processors built on the 18A node — a concrete proof point that the technology is production-ready. TSMC, however, has said it will not use High-NA in mass production until at least 2029, citing prohibitive costs. Samsung goes even further: vice president of technology ChangMin Park has stated the company will not begin High-NA mass production until the 1-nanometer node A10, around 2030, arguing the technology is not yet mature enough for its current 2-nanometer and 1.4-nanometer processes.

The delays, though, apply mainly to the newest and priciest generation. The existing EUV and immersion lines remain fully utilized, which is precisely why ASML can confidently book capacity into 2028. The company's pricing power on its core products appears intact even as its most advanced offering waits for the market to catch up.

Washington's Shadow Lengthens

Adding to the mix is the geopolitical overhang that has shadowed ASML for months. The proposed MATCH Act in the United States could force the company to halt shipments of even older DUV systems to China and — in a new and more consequential detail — stop servicing machines already installed there. That service-stop provision shifts the China risk from a future concern to a present one, and it is the kind of regulatory threat that no amount of order-book visibility can neutralize.

The market's reaction has been muted but telling. The stock closed Thursday at €1,500.60, down 5.6 percent over seven trading days, and is off roughly 5 percent over the past month. It sits 14 percent below its 52-week high of €1,748.00. Yet the longer-term picture remains emphatically positive: shares are up 63 percent since the start of the year, 137 percent over twelve months, and 146 percent from the low struck on September 2 of last year. The recent softness reads more like a pause after an extraordinary run than a reversal.

Wall Street Zen captured the shifting mood on Tuesday, downgrading the stock from "Buy" to "Hold" — a modest but symbolic acknowledgment that the euphoria has cooled. Meanwhile, a state-backed manufacturer in Shanghai has begun series production of its own immersion DUV lithography systems, though in negligible volumes: just five units in 2026 and twenty in 2027, destined for domestic customers such as SMIC and CXMT. It is a reminder that ASML's competitive moat, however wide, is not entirely unassailable.

What to Watch Next

The next major catalyst arrives on October 14, when ASML reports third-quarter results. With capacity confirmed as sold out through 2028, the focus will shift to how the company executes its planned 30 percent capacity expansion for 2027 and whether it can sustain pricing power in an environment where its biggest customers are openly deferring adoption of its most advanced machines.

For now, ASML remains a study in contradictions: an order book that extends years into the future, a technology lead that no competitor can match, and a shareholder base that cannot agree on whether that adds up to a buy or a sell. The answer may depend less on what ASML can build than on what Washington will allow it to sell — and what its customers are ultimately willing to pay.